Transgenic mouse models of amyotrophic lateral sclerosis.

Publication Type:

Journal Article


Biochim Biophys Acta, Volume 1762, Issue 11-12, p.1013-24 (2006)


Amyotrophic Lateral Sclerosis, Animals, Guanine Nucleotide Exchange Factors, Humans, Intermediate Filaments, Mice, Mice, Transgenic, Microtubules, Models, Neurological, Motor Neurons, Mutation, Superoxide Dismutase, Vascular Endothelial Growth Factor A


<p>The discovery of missense mutations in the gene coding for the Cu/Zn superoxide dismutase 1 (SOD1) in subsets of familial cases was rapidly followed by the generation of transgenic mice expressing various forms of SOD1 mutants. The mice overexpressing high levels of mutant SOD1 mRNAs do develop motor neuron disease but unraveling the mechanisms of pathogenesis has been very challenging. Studies with mouse lines suggest that the toxicity of mutant SOD1 is unrelated to copper-mediated catalysis but rather to propensity of a subfraction of mutant SOD1 proteins to form misfolded protein species and aggregates. However, the mechanism of toxicity of SOD1 mutants remains to be elucidated. Involvement of cytoskeletal components in ALS pathogenesis is supported by several mouse models of motor neuron disease with neurofilament abnormalities and with genetic defects in microtubule-based transport. Here, we describe how transgenic mouse models have been used for understanding pathogenic pathways of motor neuron disease and for pre-clinical drug testing.</p>

Funding / Support / Partners

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord